Cargando…
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
BACKGROUND: Although first-line therapy for patients affected by advanced mesothelioma is well established, there is a lack of data regarding the impact of second-line treatment. METHODS: We retrospectively collected data of patients affected by advanced mesothelioma, already treated with first-line...
Autores principales: | Bearz, Alessandra, Talamini, Renato, Rossoni, Gilda, Santo, Antonio, de Pangher, Vincenzo, Fasola, Gianpiero, Rosetti, Francesco, Favaretto, Adolfo, Gregorc, Vanesa, Berretta, Massimiliano, Santarossa, Sandra, Berto, Eleonora, Tirelli, Umberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502102/ https://www.ncbi.nlm.nih.gov/pubmed/22943698 http://dx.doi.org/10.1186/1756-0500-5-482 |
Ejemplares similares
-
Comment on ‘Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection’
por: Bearz, A, et al.
Publicado: (2012) -
Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report
por: Fasola, Gianpiero, et al.
Publicado: (2006) -
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials
por: Ceresoli, G L, et al.
Publicado: (2008) -
Immune checkpoint inhibitors and response analysis: a tough challenge. A case report
por: Bearz, Alessandra, et al.
Publicado: (2016) -
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
por: Federico, Rea, et al.
Publicado: (2013)